HOME >> MEDICINE >> NEWS
Pharmaceutical industry still failing health needs of less-developed countries

The third article about the role of the pharmaceutical industry in medicine--The Pharmaceutical Industry as a Medicines Provider--is published in this week's issue of THE LANCET.

David Henry from the University of Newcastle, Australia, and Joel Lexchin from the University of Toronto, Canada, discuss how rising prices of medicines are putting them beyond the reach of many people, even in rich countries. In less-developed countries, they state, millions of individuals do not have access to essential drugs, and drug development is failing to address the major health needs of these countries. The authors also comment how the prices of patented medicines usually far exceed the marginal costs of their production -- while the industry maintains that high prices and patent protection are necessary to compensate for high development costs of innovative products, there are doubts about the figures that form the basis of these claims.

David Henry comments: "The international pharmaceutical industry manufactures and distributes many good drugs, displays generosity in its philanthropic activities, and has an important role in maintenance of manufacturing standards. However, evidence shows that companies have shifted their core activities from discovery and development of innovative drugs to marketing of products that keep profit to a maximum in high-income countries."

He adds: "Access to important drugs by low-income countries is generally agreed to remain grossly inadequate. Some international manufacturers have responded to this crisis by sharp reductions in prices of some products and by donations. These moves largely seem to have been in response to external pressures, especially bad publicity and generic competition, rather than initiatives of the companies themselves. Restoration of true market forces and fair pricing of drugs is a better long term solution to shortages than 'ad hoc' donations. These issues are particularly relevant and timely
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
14-Nov-2002


Page: 1 2

Related medicine news :

1. Pharmaceutical marketing tactics hold little sway with prescribing physicians
2. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
3. Pharmaceutical Achievers
4. MetaPhore Pharmaceuticals initiates Phase I clinical trial of enzyme mimetic compound for oncology
5. Maret Pharmaceuticals presents promising Phase I/II clinical MARstem™ results at international symposium on new drugs in cancer therapy
6. NIH awards grant to MetaPhore Pharmaceuticals to study novel pain treatments
7. American Association of Pharmaceutical Scientists Dietary Supplements Forum examines science behind nutraceuticals
8. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
9. Pharmaceuticals and personal care products
10. New publisher announced for Journal Of Pharmaceutical Sciences
11. American Association of Pharmaceutical Scientists tapped to manage PQRI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2020)... , ... June 04, 2020 , ... The experience of ... coming together to collaborate on art. Then came the COVID-19 pandemic and physical distancing. ... Director of the Berlin International Film Festival (BIFF). That is, “all stages of the ...
(Date:6/2/2020)... LANSDALE, Pa. (PRWEB) , ... June 02, 2020 ... ... (RPM) and telehealth services company that has been serving the healthcare industry for ... website reflecting its expanded virtual and integrated care offerings. , In 2010, RemetricHealth, ...
(Date:5/30/2020)... ... , ... Segal Trials, a privately held network of research ... Mental Health Awareness Month, and May 20th, Clinical Trial Awareness Day, with key ... #StayConnected video series raising awareness of clinical trials and offering mental health support ...
(Date:5/28/2020)... , ... May 28, 2020 , ... ... organization is joining the clinically integrated network (CIN) and the group purchasing organization ... AHN’s Cardiovascular Institute to establish a heart failure program at Mon Health Medical ...
(Date:5/27/2020)... ... 27, 2020 , ... Productive Plastics, a leading heavy gauge ... to be used as personal protective equipment (PPE) to combat the spread ... made to be worn by frontline healthcare professionals and for any essential professional ...
Breaking Medicine News(10 mins):
(Date:6/5/2020)... ... June 04, 2020 , ... Today America’s Pharmacy ( https://www.americaspharmacy.com ) ... health benefits (and often their jobs) due to COVID-19 understand their options to finding ... Rules Survival Guide 2020” covers such topics as:, Who ...
(Date:6/5/2020)... ... ... ProAct Safety, a recognized pioneer of leadership and safety excellence strategies, announces ... and the impact on businesses during the pandemic. , In addition to publishing ... site where all these resources are available to businesses and individuals in one place. ...
(Date:6/4/2020)... ... June 04, 2020 , ... The USA based, ... and cutting-edge digital solutions for a futuristic reformation of production units. , ... across sectors, affecting the global supply chain. With social distancing protocols still prevalent, ...
Breaking Medicine Technology:
Cached News: